BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Compagnon P, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouillères O, Cherqui D, Duvoux C. Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: A multicenter study of 412 patients. World J Gastroenterol 2006; 12(45): 7319-7325 [PMID: 17143948 DOI: 10.3748/wjg.v12.i45.7319]
URL: https://www.wjgnet.com/1948-5182/full/v12/i45/7319.htm
Number Citing Articles
1
T. Decaens, M. Hurtova, C. Duvoux. Transplantation hépatique pour carcinome hépatocellulaireGastroentérologie Clinique et Biologique 2009; 33(1): 61 doi: 10.1016/j.gcb.2008.11.005
2
Wu Junyi, Sun Hongcheng, Han Zhongbo, Peng Zhihai. A single center experience: post-transplantation adjuvant chemotherapy impacts the prognosis of hepatocellular carcinoma patientsChinese Medical Journal 2014; 127(3): 430 doi: 10.3760/cma.j.issn.0366-6999.20120126
3
Utz Settmacher, Falk Rauchfuß, Michael Bauer, Astrid Bauschke, Susanne Beckebaum, Alfred Königsrainer, Christina Malessa, Silvio Nadalin, Silke Rummler, Andreas Kortgen, Lara Genedy. Organtransplantation mit Lebendspende2023; : 129 doi: 10.1007/978-3-662-65736-2_8
4
Yuan-Yuan Liu, Chang-Ping Li, Ming-Sheng Huai, Xiao-Meng Fu, Zhuang Cui, Lin-Lin Fan, Shu Zhang, Yuan Liu, Jun Ma, Guang Li, Zhong-Yang Shen, Song Guo Zheng. Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard ImmunosuppressionPLOS ONE 2015; 10(3): e0120939 doi: 10.1371/journal.pone.0120939
5
Safak Gül-Klein, Anika Kästner, Philipp Konstantin Haber, Felix Krenzien, Simon Wabitsch, Alexander Krannich, Andreas Andreou, Dennis Eurich, Frank Tacke, David Horst, Johann Pratschke, Moritz Schmelzle. Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute RejectionsJournal of Hepatocellular Carcinoma 2021; : 133 doi: 10.2147/JHC.S292010
6
Maya Horowitz, Elad Neeman, Eran Sharon, Shamgar Ben-Eliyahu. Exploiting the critical perioperative period to improve long-term cancer outcomesNature Reviews Clinical Oncology 2015; 12(4): 213 doi: 10.1038/nrclinonc.2014.224
7
Jan Lerut, Quirino Lai. Comments on: Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular CarcinomaTransplantation 2023; 107(7): 1434 doi: 10.1097/TP.0000000000004488
8
Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans J. Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0Zeitschrift für Gastroenterologie 2024; 62(02): e213 doi: 10.1055/a-2189-8567
9
Christophe Duvoux, Christian Toso. mTOR inhibitor therapy: Does it prevent HCC recurrence after liver transplantation?Transplantation Reviews 2015; 29(3): 168 doi: 10.1016/j.trre.2015.02.003
10
A. Bauschke, A. Altendorf-Hofmann, H. Kissler, A. Koch, C. Malessa, U. Settmacher. Validity of eleven prognostic scores with respect to intra- and extrahepatic recurrence of hepatocellular carcinoma after liver transplantationJournal of Cancer Research and Clinical Oncology 2017; 143(12): 2595 doi: 10.1007/s00432-017-2507-2
11
Claire Durkin, Douglas E. Schaubel, Yuwen Xu, Nadim Mahmud, David E. Kaplan, Peter L. Abt, Therese Bittermann. Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular CarcinomaTransplantation 2023; 107(7): 1524 doi: 10.1097/TP.0000000000004487
12
Aglaia Domouchtsidou, Ferdinand Beckmann, Beate Marenbach, Stefan P. Mueller, Jan Best, Ken Herrmann, Peter A. Horn, Vahé Barsegian, Monika Lindemann. In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of SurvivalCancers 2023; 15(16): 4055 doi: 10.3390/cancers15164055
13
Andreas A. Schnitzbauer, Hans J. Schlitt, Edward K. Geissler. Influence of Immunosuppressive Drugs on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Gap Between Basic Science and Clinical EvidenceTransplantation 2011; 91(11): 1173 doi: 10.1097/TP.0b013e318215e72b
14
Kan Chen, Kwan Man, Herold J. Metselaar, Harry L. A. Janssen, Maikel P. Peppelenbosch, Qiuwei Pan. Rationale of personalized immunosuppressive medication for hepatocellular carcinoma patients after liver transplantationLiver Transplantation 2014; 20(3): 261 doi: 10.1002/lt.23806
15
Maryam Moini, Michael L Schilsky, Eric M Tichy. Review on immunosuppression in liver transplantationWorld Journal of Hepatology 2015; 7(10): 1355-1368 doi: 10.4254/wjh.v7.i10.1355
16
Tsuyoshi Kadosawa, Ai Watabe. The effects of surgery-induced immunosuppression and angiogenesis on tumour growthThe Veterinary Journal 2015; 205(2): 175 doi: 10.1016/j.tvjl.2015.04.009
17
Fusheng Liu, Haitao Wang, Weijie Ma, Jinghua Li, Yingyi Liu, Shengli Tang, Kun Li, Ping Jiang, Zhiyong Yang, Yueming He, Zhisu Liu, Zhonglin Zhang, Yufeng Yuan. Short- and Long-Term Outcomes of Indocyanine Green Fluorescence Navigation- Versus Conventional-Laparoscopic Hepatectomy for Hepatocellular Carcinoma: A Propensity Score-Matched, Retrospective, Cohort StudyAnnals of Surgical Oncology 2023; 30(4): 1991 doi: 10.1245/s10434-022-13027-5
18
Stéphanie Lacotte, Graziano Oldani, Florence Slits, Lorenzo A. Orci, Laura Rubbia-Brandt, Philippe Morel, Gilles Mentha, Christian Toso, Jacques Zimmer. Alloimmune Activation Promotes Anti-Cancer Cytotoxicity after Rat Liver TransplantationPLoS ONE 2014; 9(3): e91515 doi: 10.1371/journal.pone.0091515
19
Andrea Notarpaolo, Richard Layese, Paolo Magistri, Maria Gambato, Michele Colledan, Giulia Magini, Lucia Miglioresi, Alessandro Vitale, Giovanni Vennarecci, Cecilia D Ambrosio, Patrizia Burra, Fabrizio Di Benedetto, Stefano Fagiuoli, Marco Colasanti, Giuseppe Maria Ettorre, Arnoldo Andreoli, Umberto Cillo, Alexis Laurent, Sandrine Katsahian, Etienne Audureau, Françoise Roudot-Thoraval, Christophe Duvoux. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCCJournal of Hepatology 2017; 66(3): 552 doi: 10.1016/j.jhep.2016.10.038
20
Sun Kyung Jang, Gi Hong Choi, Junjeong Choi, Xiaoyuan Quan, Jeong Won Jang, Bo Hyun Kim, Guhung Jung, Young Min Park. Co-expression patterns of Notch1, Snail, and p53 in grade III hepatocellular carcinoma with postoperative recurrence: a preliminary studyThe Korean Journal of Hepatology 2012; 18(1): 63 doi: 10.3350/kjhep.2012.18.1.63
21
Christian Toso, Sonia Cader, Ariane Mentha‐Dugerdil, Glenda Meeberg, Pietro Majno, Isabelle Morard, Emiliano Giostra, Thierry Berney, Philippe Morel, Gilles Mentha, Norman M. Kneteman. Factors predicting survival after post‐transplant hepatocellular carcinoma recurrenceJournal of Hepato-Biliary-Pancreatic Sciences 2013; 20(3): 342 doi: 10.1007/s00534-012-0528-4
22
François Durand, Claire Francoz. Evidence‐based Gastroenterology and Hepatology 4e2019; : 729 doi: 10.1002/9781119211419.ch48
23
K. Dudek, O. Kornasiewicz, P. Remiszewski, K. Kobryń, B. Ziarkiewicz-Wróblewska, B. Górnicka, K. Zieniewicz, M. Krawczyk. Impact of Tumor Characteristic on the Outcome of Liver Transplantation in Patients With Hepatocellular CarcinomaTransplantation Proceedings 2009; 41(8): 3135 doi: 10.1016/j.transproceed.2009.08.016
24
François Durand, Claire Francoz, Jacques Belghiti. Malignant Liver Tumors2010; : 281 doi: 10.1002/9781444317053.ch23
25
Christophe Duvoux, Tetsuya Kiuchi, Bernhard Pestalozzi, Ronald Busuttil, Rebecca Miksad. What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma?Liver Transplantation 2011; 17(S2): S147 doi: 10.1002/lt.22367
26
Monika Hurtova, Thomas Decaens, Alexis Laurent, Daniel Cherqui, Christophe Duvoux. Transplantation hépatique pour carcinome hépatocellulaire et chez les malades avec antécédents de cancerLa Presse Médicale 2009; 38(9): 1272 doi: 10.1016/j.lpm.2009.05.001
27
Michael A. Zimmerman, Mara A. Kelly, Jeffrey Campsen, M. Susan Mandell, Michael Wachs, Tom Bak, Afshin Skibba, Brian Lancaster, Igal Kam. The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantationClinical Transplantation 2010; 24(4) doi: 10.1111/j.1399-0012.2009.01179.x
28
Elad Neeman, Shamgar Ben-Eliyahu. Surgery and stress promote cancer metastasis: New outlooks on perioperative mediating mechanisms and immune involvementBrain, Behavior, and Immunity 2013; 30: S32 doi: 10.1016/j.bbi.2012.03.006
29
Emad H. Asham, Ahmed Kaseb, R. Mark Ghobrial. Management of Hepatocellular CarcinomaSurgical Clinics of North America 2013; 93(6): 1423 doi: 10.1016/j.suc.2013.08.008
30
Julie K. Heimbach. Liver Transplantation for Hepatocellular CarcinomaThe Cancer Journal 2008; 14(2): 95 doi: 10.1097/PPO.0b013e31816a0f6f
31
T. Decaens, C. Duvoux. Carcinome hépatocellulaire et transplantation hépatique : rôle futur des inhibiteurs de la mTORGastroentérologie Clinique et Biologique 2009; 33: S257 doi: 10.1016/S0399-8320(09)73163-X
32
EASL Clinical Practice Guidelines: Liver transplantationJournal of Hepatology 2016; 64(2): 433 doi: 10.1016/j.jhep.2015.10.006
33
Poh Seng Tan, Mark D. Muthiah, Tsingyi Koh, Yee Leong Teoh, Albert Chan, Alfred Kow, Qishi Zheng, Choon Hyuck David Kwon, Guan Huei Lee, Cosmas Rinaldi A. Lesmana, Vanessa de Villa, James Fung, Kieron Lim. Asian Liver Transplant Network Clinical Guidelines on Immunosuppression in Liver TransplantationTransplantation 2019; 103(3): 470 doi: 10.1097/TP.0000000000002532
34
Jérôme Dumortier, Sebastien Dharancy, Yvon Calmus, Christophe Duvoux, François Durand, Ephrem Salamé, Faouzi Saliba. Use of everolimus in liver transplantation: The French experienceTransplantation Reviews 2016; 30(3): 161 doi: 10.1016/j.trre.2015.12.003
35
A. R. Hakeem, R. S. Young, G. Marangoni, J. P. A. Lodge, K. R. Prasad. Systematic review: the prognostic role of alpha‐fetoprotein following liver transplantation for hepatocellular carcinomaAlimentary Pharmacology & Therapeutics 2012; 35(9): 987 doi: 10.1111/j.1365-2036.2012.05060.x
36
Letizia Todeschini, Luca Cristin, Alessandro Martinino, Amelia Mattia, Salvatore Agnes, Francesco Giovinazzo. The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular CarcinomaCurrent Oncology 2023; 30(6): 5574 doi: 10.3390/curroncol30060421
37
Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0Zeitschrift für Gastroenterologie 2024; 62(01): e67 doi: 10.1055/a-2189-6353
38
Nicholas Onaca, Marvin J. Stone, James M. Fulmer, Göran B.G. Klintmalm. Transplantation of the Liver2015; : 189 doi: 10.1016/B978-1-4557-0268-8.00016-6
39
Vincent Donckier, Ligia Craciun, Patrick Miqueu, Roberto Ivan Troisi, Valerio Lucidi, Xavier Rogiers, Nathalie Boon, Delphine Degré, Alexis Buggenhout, Christophe Moreno, Thierry Gustot, Maurizio Sainz-Barriga, Nadine Bourgeois, Isabelle Colle, Hans Van Vlierberghe, Mohammed Amrani, Myriam Remmelink, Arnaud Lemmers, Dave L. Roelen, Frans H. Claas, Petra Reinke, Birgit Sawitzki, Hans Dieter Volk, Alain Le Moine, Bernard de Hemptinne, Michel Goldman. Expansion of Memory-Type CD8+ T Cells Correlates With the Failure of Early Immunosuppression Withdrawal After Cadaver Liver Transplantation Using High-Dose ATG Induction and RapamycinTransplantation 2013; 96(3): 306 doi: 10.1097/TP.0b013e3182985414
40
Christian Toso, Glenda Meeberg, Roberto Hernandez‐Alejandro, Jean‐François Dufour, Paul Marotta, Pietro Majno, Norman M. Kneteman. Total tumor volume and alpha‐fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validationHepatology 2015; 62(1): 158 doi: 10.1002/hep.27787
41
C.P. Strassburg, M.J. Bahr, T. Becker, J. Klempnauer, M.P. Manns. Fortschritte in der ImmunsuppressionDer Chirurg 2008; 79(2): 149 doi: 10.1007/s00104-007-1456-8
42
Elad Neeman, Oded Zmora, Shamgar Ben-Eliyahu. A New Approach to Reducing Postsurgical Cancer Recurrence: Perioperative Targeting of Catecholamines and ProstaglandinsClinical Cancer Research 2012; 18(18): 4895 doi: 10.1158/1078-0432.CCR-12-1087
43
Michael Bitzer, Sabrina Groß, Jörg Albert, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, Achim Kautz, David Krug, Christian La Fougère, Hauke Lang, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – LangversionZeitschrift für Gastroenterologie 2023; 61(04): e92 doi: 10.1055/a-2026-1240
44
Daniel Hoffman, Neil Mehta. Recurrence of hepatocellular carcinoma following liver transplantationExpert Review of Gastroenterology & Hepatology 2021; 15(1): 91 doi: 10.1080/17474124.2021.1823213
45
Ju-Yeun Lee, Yul Hee Kim, Nam-Joon Yi, Hyang Sook Kim, Hye Suk Lee, Byung Koo Lee, Hyeyoung Kim, Young Rok Choi, Geun Hong, Kwang-Woong Lee, Kyung-Suk Suh. Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantationClinical and Molecular Hepatology 2014; 20(2): 192 doi: 10.3350/cmh.2014.20.2.192
46
Olga Ciccarelli, Quirino Lai, Pierre Goffette, Patrice Finet, Chantal De Reyck, Francine Roggen, Christine Sempoux, Erik Doffagne, Raymond Reding, Jan Lerut. Liver transplantation for hepatocellular cancer: UCL experience in 137 adult cirrhotic patients. Alpha-foetoprotein level and locoregional treatment as refined selection criteriaTransplant International 2012; 25(8): 867 doi: 10.1111/j.1432-2277.2012.01512.x
47
Incheon Kang, Jae Geun Lee, Sung Hoon Choi, Hyun Jeong Kim, Dai Hoon Han, Gi Hong Choi, Myoung Soo Kim, Jin Sub Choi, Soon Il Kim, Dong Jin Joo. Impact of everolimus on survival after liver transplantation for hepatocellular carcinomaClinical and Molecular Hepatology 2021; 27(4): 589 doi: 10.3350/cmh.2021.0038
48
Christophe Duvoux, Françoise Roudot–Thoraval, Thomas Decaens, Fabienne Pessione, Hanaa Badran, Tullio Piardi, Claire Francoz, Philippe Compagnon, Claire Vanlemmens, Jérome Dumortier, Sébastien Dharancy, Jean Gugenheim, Pierre–Henri Bernard, René Adam, Sylvie Radenne, Fabrice Muscari, Filomena Conti, Jean Hardwigsen, Georges–Philippe Pageaux, Olivier Chazouillères, Ephrem Salame, Marie–Noelle Hilleret, Pascal Lebray, Armand Abergel, Marilyne Debette–Gratien, Michael D. Kluger, Ariane Mallat, Daniel Azoulay, Daniel Cherqui. Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan CriteriaGastroenterology 2012; 143(4): 986 doi: 10.1053/j.gastro.2012.05.052
49
Wei Geng, Chung-Mau Lo, Kevin T.P. Ng, Chang-Chun Ling, Xiang Qi, Chang-Xian Li, Yuan Zhai, Xiao-Bing Liu, Yuen-Yuen Ma, Kwan Man. Interferon-gamma inducible protein 10 (IP10) induced cisplatin resistance of HCC after liver transplantation through ER stress signaling pathwayOncotarget 2015; 6(29): 28042 doi: 10.18632/oncotarget.4832
50
Jan Lerut, Olivier Julliard, Olga Ciccarelli, Valerie Lannoy, Pierre Gofette. Multidisciplinary Treatment of Hepatocellular CarcinomaRecent Results in Cancer Research 2013; 190: 127 doi: 10.1007/978-3-642-16037-0_9
51
Sara M. Lewin, Neil Mehta, R. Kate Kelley, John P. Roberts, Francis Y. Yao, Danielle Brandman. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinomaLiver Transplantation 2017; 23(8): 1015 doi: 10.1002/lt.24764
52
Steven C. Cunningham, Susan Tsai, Hugo P. Marques, Paulo Mira, Andrew Cameron, Eduardo Barroso, Benjamin Philosophe, Timothy M. Pawlik. Management of Early Hepatocellular Carcinoma in Patients with Well-Compensated CirrhosisAnnals of Surgical Oncology 2009; 16(7): 1820 doi: 10.1245/s10434-009-0364-1
53
A. Hollebecque, T. Decaens, E. Boleslawski, P. Mathurin, C. Duvoux, F.-R. Pruvot, S. Dharancy. Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantationGastroentérologie Clinique et Biologique 2009; 33(5): 361 doi: 10.1016/j.gcb.2009.02.036
54
Lionel Rostaing, Faouzi Saliba, Yvon Calmus, Sébastien Dharancy, Olivier Boillot. Review article: Use of induction therapy in liver transplantationTransplantation Reviews 2012; 26(4): 246 doi: 10.1016/j.trre.2012.06.002
55
C. Toso, G. Mentha, P. Majno. Liver Transplantation for Hepatocellular Carcinoma: Five Steps to Prevent RecurrenceAmerican Journal of Transplantation 2011; 11(10): 2031 doi: 10.1111/j.1600-6143.2011.03689.x
56
Voesch Sabrina, Bitzer Michael, Albert Jörg, Bartenstein Peter, Bechstein Wolf, Blödt Susanne, Brunner Thomas, Dombrowski Frank, Evert Matthias, Follmann Markus, La Fougère Christian, Freudenberger Paul, Geier Andreas, Gkika Eleni, Götz Martin, Hammes Elke, Helmberger Thomas, Hoffmann Ralf-Thorsten, Hofmann Wolf-Peter, Huppert Peter, Kautz Achim, Knötgen Gabi, Körber Jürgen, Krug David, Lammert Frank, Lang Hauke, Langer Thomas, Lenz Philipp, Mahnken Andreas, Meining Alexander, Micke Oliver, Nadalin Silvio, Nguyen Huu Phuc, Ockenga Johann, Oldhafer Karl-Jürgen, Paprottka Philipp, Paradies Kerstin, Pereira Philippe, Persigehl Thorsten, Plauth Mathias, Plentz Ruben, Pohl Jürgen, Riemer Jutta, Reimer Peter, Ringwald Johanna, Ritterbusch Ulrike, Roeb Elke, Schellhaas Barbara, Schirmacher Peter, Schmid Irene, Schuler Andreas, von Schweinitz Dietrich, Seehofer Daniel, Sinn Marianne, Stein Alexander, Stengel Andreas, Steubesand Nadine, Stoll Christian, Tannapfel Andrea, Taubert Anne, Trojan Jörg, van Thiel Ingo, Tholen Reina, Vogel Arndt, Vogl Thomas, Vorwerk Hilke, Wacker Frank, Waidmann Oliver, Wedemeyer Heiner, Wege Henning, Wildner Dane, Wittekind Christian, Wörns Marcus-Alexander, Galle Peter, Malek Nisar. S3-Leitlinie: Diagnostik und Therapie des hepatozellulären KarzinomsZeitschrift für Gastroenterologie 2022; 60(01): e56 doi: 10.1055/a-1589-7568